These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 36183076)

  • 1. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report.
    Prasad S; Gaur A; Mehta A; Kaushal N
    BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
    Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
    Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
    Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
    Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis in a patient with COVID-19 with uncontrolled diabetes.
    Shakir M; Maan MHA; Waheed S
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34326123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophtalmoplegia complicating sino-orbital mucormycosis.
    Zbiba W; Bouayed E; Ben Abdesslem N; Elleuch I; Kharrat M
    Tunis Med; 2018 Mar; 96(3):224-226. PubMed ID: 30325492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cirrhosis and rhino-orbital mucormycosis, a possible but rare association: description of a clinical case and literature review.
    Pellicelli AM; D'Ambrosio C; Villani R; Cerasari G; Ialongo P; Cortese A; Grillo LR; Soccorsi F
    Braz J Infect Dis; 2009 Aug; 13(4):314-6. PubMed ID: 20231998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.
    Goel R; Arora R; Shah S; Chhabra M; Kumar J; Khurana N; Gupta S; Khanam S; Kumar S; Singh S; Meher R; Thakar M; Garg A
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):242-249. PubMed ID: 34919070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal Orbital Cellulitis: Presenting Features, Management and Outcomes at a Referral Center.
    Farooq AV; Patel RM; Lin AY; Setabutr P; Sartori J; Aakalu VK
    Orbit; 2015 Jun; 34(3):152-9. PubMed ID: 25906127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous retinal detachment in a patient with rhino-orbital mucormycosis.
    Kim IT; Shim JY; Jung BY
    Jpn J Ophthalmol; 2001; 45(3):301-4. PubMed ID: 11369382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
    Pelton RW; Peterson EA; Patel BC; Davis K
    Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
    Mitra S; Janweja M; Sengupta A
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
    Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
    Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
    Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
    Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.